Marostica E - Search Results

1

Population modelling of patient responses in antidepressant studies: a stochastic approach.

Marostica E, Russu A, Gomeni R, Zamuner S, De Nicolao G. Marostica E, et al. Math Biosci. 2015 Mar;261:37-47. doi: 10.1016/j.mbs.2014.11.007. Epub 2014 Dec 4. Math Biosci. 2015. PMID: 25481225

2

A PCA approach to population analysis: with application to a Phase II depression trial.

Marostica E, Russu A, Gomeni R, Zamuner S, De Nicolao G. Marostica E, et al. J Pharmacokinet Pharmacodyn. 2013 Apr;40(2):213-27. doi: 10.1007/s10928-013-9304-6. Epub 2013 Mar 17. J Pharmacokinet Pharmacodyn. 2013. PMID: 23504512 Clinical Trial.

3

Population model of longitudinal FEV1 data in asthmatics: meta-analysis and predictability of placebo response.

Marostica E, Russu A, Yang S, De Nicolao G, Zamuner S, Beerahee M. Marostica E, et al. J Pharmacokinet Pharmacodyn. 2014 Dec;41(6):553-69. doi: 10.1007/s10928-014-9373-1. Epub 2014 Aug 15. J Pharmacokinet Pharmacodyn. 2014. PMID: 25123552

4

Continuous-time Markov modelling of flexible-dose depression trials.

Marostica E, Russu A, Gomeni R, Zamuner S, De Nicolao G. Marostica E, et al. J Pharmacokinet Pharmacodyn. 2014 Dec;41(6):625-38. doi: 10.1007/s10928-014-9389-6. Epub 2014 Oct 4. J Pharmacokinet Pharmacodyn. 2014. PMID: 25281421

5

Joint modeling of efficacy, dropout, and tolerability in flexible-dose trials: a case study in depression.

Russu A, Marostica E, De Nicolao G, Hooker AC, Poggesi I, Gomeni R, Zamuner S. Russu A, et al. Among authors: marostica e. Clin Pharmacol Ther. 2012 May;91(5):863-71. doi: 10.1038/clpt.2011.322. Clin Pharmacol Ther. 2012. PMID: 22472989 Clinical Trial.

6

Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies.

Marostica E, Sukbuntherng J, Loury D, de Jong J, de Trixhe XW, Vermeulen A, De Nicolao G, O'Brien S, Byrd JC, Advani R, McGreivy J, Poggesi I. Marostica E, et al. Cancer Chemother Pharmacol. 2015 Jan;75(1):111-21. doi: 10.1007/s00280-014-2617-3. Epub 2014 Nov 8. Cancer Chemother Pharmacol. 2015. PMID: 25381051 Clinical Trial.

7

The GHRH + arginine stimulated pituitary GH secretion in children and adults with Prader-Willi syndrome shows age- and BMI-dependent and genotype-related differences.

Marostica E, Grugni G, De Nicolao G, Marazzi N, Crinò A, Cappa M, Sartorio A. Marostica E, et al. Growth Horm IGF Res. 2013 Dec;23(6):261-6. doi: 10.1016/j.ghir.2013.09.004. Epub 2013 Sep 19. Growth Horm IGF Res. 2013. PMID: 24090687

8

Deconvolution-based assessment of pituitary GH secretion stimulated with GHRH+arginine in Prader-Willi adults and obese controls.

Grugni G, Marostica E, Crinò A, Marzullo P, De Nicolao G, Sartorio A. Grugni G, et al. Among authors: marostica e. Clin Endocrinol (Oxf). 2013 Aug;79(2):224-31. doi: 10.1111/cen.12142. Epub 2013 Apr 5. Clin Endocrinol (Oxf). 2013. PMID: 23301953

9

Modelling of drug-induced QT-interval prolongation: estimation approaches and translational opportunities.

Marostica E, Van Ammel K, Teisman A, Boussery K, Van Bocxlaer J, De Ridder F, Gallacher D, Vermeulen A. Marostica E, et al. J Pharmacokinet Pharmacodyn. 2015 Dec;42(6):659-79. doi: 10.1007/s10928-015-9434-0. Epub 2015 Aug 11. J Pharmacokinet Pharmacodyn. 2015. PMID: 26259721

10

Pharmacokinetic analysis of modified-release metoprolol formulations: An interspecies comparison.

De Thaye E, Vervaeck A, Marostica E, Remon JP, Van Bocxlaer J, Vervaet C, Vermeulen A. De Thaye E, et al. Among authors: marostica e. Eur J Pharm Sci. 2017 Jan 15;97:135-142. doi: 10.1016/j.ejps.2016.10.039. Epub 2016 Nov 2. Eur J Pharm Sci. 2017. PMID: 27816630 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters